Related Experiment Video

Updated: May 19, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Alveolar soft part sarcoma: should we be targeting the tumor or targeting the vasculature?

Jaap Verweij

    Onkologie
    |August 8, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
    09:33

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

    Published on: March 20, 2026

    Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
    06:53

    Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

    Published on: September 9, 2020

    Related Experiment Videos

    Last Updated: May 19, 2026

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

    Published on: July 28, 2020

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
    09:33

    Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

    Published on: March 20, 2026

    Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
    06:53

    Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

    Published on: September 9, 2020

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Challenges and Potential Solutions to Advance Global Cancer Drug Development.

    Therapeutic innovation & regulatory science·2026

    Empowering effective biomarker-driven precision oncology: A call to action.

    European journal of cancer (Oxford, England : 1990)·2024

    A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2021

    Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe.

    Cancers·2020

    Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.

    Breast cancer research and treatment·2019

    Surrogate endpoints in advanced sarcoma trials: a meta-analysis.

    Oncotarget·2018

    Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma.

    Onkologie·2013

    Metastatic germ cell tumour following renal transplantation.

    Onkologie·2013

    miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.

    Onkologie·2013

    A meta-analysis of internal mammary lymph node metastasis in breast cancer patients.

    Onkologie·2013

    Patient-related delay in presentation for cutaneous squamous cell carcinoma. A cross-sectional clinical study.

    Onkologie·2013

    Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998.

    Onkologie·2013
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us